Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion

9 Jun 2017

Abstract excerpt

// Varalee Yodsurang 1 , Chizu Tanikawa 2 , Takafumi Miyamoto 2 , Paulisally Hau Yi Lo 2 , Makoto Hirata 2 and Koichi Matsuda 1,2 1 Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Minato, Tokyo, Japan 2 Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28915553
DOI: 10.18632/oncotarget.18433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasionPMID 28915553Read ↗

Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.Semantic proximity Read ↗

Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysisSemantic proximity Read ↗

Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancerSemantic proximity Read ↗

Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expressionSemantic proximity Read ↗

Increased Expression of MMP17 Predicts Poor Clinical Outcomes in Epithelial Ovarian Cancer PatientsSemantic proximity Read ↗

In silico prediction and experimental validation of MIR17HG long non-coding RNA, MIR17HG-derived miRNAs and GPC5 expression profile in Breast CancerSemantic proximity Read ↗

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancerSemantic proximity Read ↗

Keratin 17 is a prognostic biomarker in endometrial carcinoma and correlates with immune invasionSemantic proximity Read ↗

KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis.Semantic proximity Read ↗

The important molecular markers on chromosome 17 and their clinical impact in breast cancer.Semantic proximity Read ↗

New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cellsSemantic proximity Read ↗

MiR‐17‐5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.